Safety of Gemtuzumab Ozogamicin As Monotherapy or Combination Therapy in an Expanded-Access Protocol for Patients with Relapsed or Refractory Acute Myeloid Leukemia
- Resource Type
- Abstract
- Source
- In
Blood 29 November 2018 132 Supplement 1:3979-3979 - Subject
- Language
- ISSN
- 0006-4971